Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Netarsudil dimesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Netarsudil dimesylate, including repackagers and relabelers. The FDA regulates Netarsudil dimesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Netarsudil dimesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Netarsudil dimesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Netarsudil dimesylate supplier is an individual or a company that provides Netarsudil dimesylate active pharmaceutical ingredient (API) or Netarsudil dimesylate finished formulations upon request. The Netarsudil dimesylate suppliers may include Netarsudil dimesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Netarsudil dimesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Netarsudil dimesylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Netarsudil dimesylate active pharmaceutical ingredient (API) in detail. Different forms of Netarsudil dimesylate DMFs exist exist since differing nations have different regulations, such as Netarsudil dimesylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Netarsudil dimesylate DMF submitted to regulatory agencies in the US is known as a USDMF. Netarsudil dimesylate USDMF includes data on Netarsudil dimesylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Netarsudil dimesylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Netarsudil dimesylate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Netarsudil dimesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Netarsudil dimesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Netarsudil dimesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Netarsudil dimesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Netarsudil dimesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Netarsudil dimesylate suppliers with NDC on PharmaCompass.
Netarsudil dimesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Netarsudil dimesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Netarsudil dimesylate GMP manufacturer or Netarsudil dimesylate GMP API supplier for your needs.
A Netarsudil dimesylate CoA (Certificate of Analysis) is a formal document that attests to Netarsudil dimesylate's compliance with Netarsudil dimesylate specifications and serves as a tool for batch-level quality control.
Netarsudil dimesylate CoA mostly includes findings from lab analyses of a specific batch. For each Netarsudil dimesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Netarsudil dimesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Netarsudil dimesylate EP), Netarsudil dimesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Netarsudil dimesylate USP).
LOOKING FOR A SUPPLIER?
